Aptabio Therapeutics, Inc.

Aptabio Therapeutics, Inc.

KKRX:293780
6,240.00
KRW
-500.00
(-7.42%)
-541.63EPS
129.51BMarket Cap

Latest Stock Split

Aug 24, 2021

2:1

For every share held, investors received 2. The price per share adjusted from $101300.00 to $50650.00.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Aug 24, 2021
    Before$101300.00
    Split ratio2:1
    After$50650.00
    Forward

About Aptabio Therapeutics, Inc. stock splits

Aptabio Therapeutics, Inc. (KRX:293780) operates in the Pharmaceuticals: major industry.

Aptabio Therapeutics, Inc. company overview

When did Aptabio Therapeutics, Inc. stock split?

Aptabio Therapeutics, Inc.'s most recent stock split was on August 24, 2021. It was a 2-for-1 forward split, so shareholders received 2 shares for every share they held.

How many times has Aptabio Therapeutics, Inc. stock split?

Aptabio Therapeutics, Inc. has split its stock once. This history records one forward split, on August 24, 2021.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Aptabio Therapeutics, Inc.'s 2-for-1 split on August 24, 2021, every share became 2 shares.

Will Aptabio Therapeutics, Inc. split its stock again?

Aptabio Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on August 24, 2021, 5 years ago. Companies announce splits in advance, and any new KRX:293780 split will appear on this page.